Results 11 to 20 of about 257,222 (353)

HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases

Frontiers in Medicine, 2021
Hepatitis B virus (HBV) infection is a common contributor to chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Approximately 10% of people with human immunodeficiency virus (HIV) also have chronic HBV co-infection, owing to shared ...
Zhimeng Cheng, Panpan Lin, Nansheng Cheng   +2 more
doaj   +1 more source

Diagnostic-therapeutic management of bile duct cancer. [PDF]

World J Clin Cases, 2019
Huguet JM, Lobo M, Labrador JM, Boix C, Albert C, Ferrer-Barceló L, Durá AB, Suárez P, Iranzo I, Gil-Raga M, de Burgos CB, Sempere J.   +11 more
europepmc   +3 more sources

Gastric cancer simultaneously complicated with extrahepatic bile duct metastasis and portal vein tumor thrombus: a case report

Surgical Case Reports, 2023
Background Gastric cancer metastatic to the extrahepatic bile duct or accompanied by portal vein tumor thrombus (PVTT) is rare. To our knowledge, there have been no cases complicated with both of these factors.
Naohiko Otsuka, Yasuhiko Nakagawa, Hiroshi Uchinami, Yuzo Yamamoto, Junichi Arita   +4 more
doaj   +1 more source

Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini. [PDF]

PLoS Neglected Tropical Diseases, 2012
Opisthorchis viverrini is considered among the most important of the food-borne trematodes due to its strong association with advanced periductal fibrosis and bile duct cancer (cholangiocarcinoma).
Banchob Sripa, Bandit Thinkhamrop, Eimorn Mairiang, Thewarach Laha, Sasithorn Kaewkes, Paiboon Sithithaworn, Maria Victoria Periago, Vajarabhongsa Bhudhisawasdi, Ponlapat Yonglitthipagon, Jason Mulvenna, Paul J Brindley, Alex Loukas, Jeffrey M Bethony   +12 more
doaj   +1 more source

Synchronous Primary Adenocarcinoma of Distal Common Bile Duct and Gall bladder

Journal of Nepal Health Research Council, 2022
Synchronous primary cancer of the gall bladder and distal common bile duct is rare. There are only few case reports and case series available of these synchronous cancers. Management of this tumor is individualized in these case reports and series based
Tanka Prasad Bohara, Sanjaya Paudyal, Prakash Chaudhary, Mukund Raj Joshi   +3 more
doaj   +1 more source

Application of ERCP in diagnosis and treatment of biliary complications during perioperative period of primary liver cancer [PDF]

Waike lilun yu shijian, 2023
Objective: To review the experience of using endoscopic retrograde cholangio-pancreatography (ERCP) in the clinical diagnosis and treatment of biliary complications during perioperative period of primary liver cancer at our hospital.
YE Feng, GONG Xiaoyong, REN Jiajun, CAI Qiang, CHEN Sheng
doaj   +1 more source

Lower bile duct metastasis from rectal cancer after surgery for liver metastasis and intrahepatic bile duct metastasis: a case report

BMC Surgery, 2020
Background Biliary metastasis of colorectal cancer is a manifestation of metastatic liver carcinoma, and is often difficult to differentiate from cholangiocarcinoma. Further, lower bile duct metastasis of colorectal cancer is rare.
Yoichi Nakagawa, Atsuyuki Maeda, Kazuaki Seita, Yuji Kaneoka   +3 more
doaj   +1 more source

Durable response to the combination of pembrolizumab and nab-paclitaxel in a metastatic extrahepatic cholangiocarcinoma: A case report and literature review

Frontiers in Pharmacology, 2022
Background: Cholangiocarcinoma (CCA) is a highly aggressive malignant tumor with poor overall survival. Although the first-line standard chemotherapy (gemcitabine plus cisplatin) combined with immunotherapy has yielded positive results with survival ...
Sirui Tan, Jing Yu, Qiyue Huang, Nan Zhou, Xianze Xiong, Hongfeng Gou   +5 more
doaj   +1 more source

Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla [PDF]

, 2012
Background: Pancreatic cancer, including cancer of the ampulla of Vater and bile duct, is very aggressive and has a poor five year survival rate; improved methods of patient stratification are required. Methods: We assessed the expression of calpain-1,
A Glading, A Jemal, Abed M Zaitoun, Arvind Arora, C Schafer, DE Goll, Dileep N Lobo, E Costello, G Parnaud, H Weber, I Goncalves, J Cong, J Valle, Lindy G Durrant, LM McShane, ME Valsecchi, P Ghaneh, PY Fong, R Stifanese, RA Hanna, RA Smith, RL Camp, RW Neumar, S Imajoh, S Li, Sarah J Storr, SJ Storr, SJ Storr, SJ Storr, Srinivasan Madhusudan, Stewart G Martin, T Kumamoto, T Moldoveanu   +32 more
core   +3 more sources

Incidence, mortality and survival of gallbladder, extrahepatic bile duct, and pancreatic cancer using Korea central cancer registry database: 1999-2019

Annals of Hepato-Biliary-Pancreatic Surgery, 2022
Backgrounds/Aims In Korea, pancreatic cancer and “gallbladder and extrahepatic bile duct cancer” were ranked the 8th and 9th most frequent cancers in 2019 and the 4th and 6th most common causes of cancer deaths in 2020, respectively.
M. Kang, E. Yun, K. Jung, Sang-Jae Park
semanticscholar   +1 more source